BIO-key swaps 19% equity stake for $5M Boumarang shares to regain Nasdaq compliance

BIO KEY INTERNATIONAL INC

Exchanged 595,000 shares (19% of outstanding) for 5M Boumarang shares valued at $5M ($1/share).
Transaction increased stockholders' equity by $5M, above Nasdaq's $2.5M minimum requirement.
Nasdaq approved compliance plan in Aug. 2024; this deal aims to satisfy the equity requirement.
Boumarang shares valued at $1 each based on due diligence; no public market disclosed.
Nasdaq will continue monitoring; delisting risk remains if equity drops below minimum at next report.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.